These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

189 related items for PubMed ID: 13909460

  • 1. [A metabolic disease of muscles: the absence of phosphorylase (McArdle-Schmid-Pearson disease)].
    SCHULLER E.
    Presse Med (1893); 1962 Mar 24; 70():715-7. PubMed ID: 13909460
    [No Abstract] [Full Text] [Related]

  • 2. A metabolic myopathy due to absence of muscle phosphorylase.
    PEARSON CM, RIMER DG, MOMMAERTS WF.
    Am J Med; 1961 Apr 24; 30():502-17. PubMed ID: 13733779
    [No Abstract] [Full Text] [Related]

  • 3. McArdle's syndrome: phosphorylase-deficient myopathy.
    MELLICK RS, MAHLER RF, HUGHES BP.
    Lancet; 1962 May 19; 1(7238):1045-8. PubMed ID: 14472393
    [No Abstract] [Full Text] [Related]

  • 4. In McArdle disease, phosphorylase deficiency is the tip of an iceberg.
    Willner JH, Cerri CG, Wood DS, Ponzetto-Zimmerman C, Reydel PM.
    Trans Am Neurol Assoc; 1981 May 19; 106():208-9. PubMed ID: 6294950
    [No Abstract] [Full Text] [Related]

  • 5. [Hepatic glycogenoses. Correlations between the clinical and biochemical characteristics and the type of enzymatic deficiency: glucose-6-phosphatase, amylo-1-6-glucosidase, phosphorylase].
    GABILAN JC.
    Rev Int Hepatol; 1960 May 19; 10():699-818. PubMed ID: 13702771
    [No Abstract] [Full Text] [Related]

  • 6. [Glycogenosis type V of adults: muscle phosphorylase deficiency].
    Coll Cantí J, Illa I, Beleta J, Anglada A, Pradas J, González Sastre F, Grau Veciana JM, Gella FJ.
    Med Clin (Barc); 1986 Mar 01; 86(8):335-8. PubMed ID: 3458989
    [No Abstract] [Full Text] [Related]

  • 7. Muscle glycogen phosphorylase deficiency.
    Moses SW.
    Isr J Med Sci; 1989 Feb 01; 25(2):61-3. PubMed ID: 2703327
    [No Abstract] [Full Text] [Related]

  • 8. Molecular mechanisms of McArdle's disease (muscle glycogen phosphorylase deficiency). RNA and DNA analysis.
    Gautron S, Daegelen D, Mennecier F, Dubocq D, Kahn A, Dreyfus JC.
    J Clin Invest; 1987 Jan 01; 79(1):275-81. PubMed ID: 3466902
    [Abstract] [Full Text] [Related]

  • 9. Phosphorylase and glycogen levels in skeletal muscle of mice with hereditary myopathy.
    LEONARD SL.
    Proc Soc Exp Biol Med; 1957 Dec 01; 96(3):720-2. PubMed ID: 13505838
    [No Abstract] [Full Text] [Related]

  • 10. McArdle disease: phosphorylase activity in regenerating muscle fibers.
    Mitsumoto H.
    Neurology; 1979 Feb 01; 29(2):258-62. PubMed ID: 285339
    [Abstract] [Full Text] [Related]

  • 11. Absence of functional messenger RNA for glycogen phosphorylase in the muscle of two patients with McArdle's disease.
    Daegelen D, Munnich A, Levin MJ, Girault A, Goasguen J, Kahn A, Dreyfus JC.
    Ann Hum Genet; 1983 May 01; 47(2):107-15. PubMed ID: 6576726
    [Abstract] [Full Text] [Related]

  • 12. Phosphorylase re-expression, increase in the force of contraction and decreased fatigue following notexin-induced muscle damage and regeneration in the ovine model of McArdle disease.
    Howell JM, Walker KR, Creed KE, Dunton E, Davies L, Quinlivan R, Karpati G.
    Neuromuscul Disord; 2014 Feb 01; 24(2):167-77. PubMed ID: 24309536
    [Abstract] [Full Text] [Related]

  • 13. Adenovirus-mediated delivery into myocytes of muscle glycogen phosphorylase, the enzyme deficient in patients with glycogen-storage disease type V.
    Baqué S, Newgard CB, Gerard RD, Guinovart JJ, Gómez-Foix AM.
    Biochem J; 1994 Dec 15; 304 ( Pt 3)(Pt 3):1009-14. PubMed ID: 7818463
    [Abstract] [Full Text] [Related]

  • 14. Metabolic basis of improved exercise tolerance: muscle phosphorylase deficiency after glucagon administration.
    Kono N, Mineo I, Sumi S, Shimizu T, Kang J, Nonaka K, Tarui S.
    Neurology; 1984 Nov 15; 34(11):1471-6. PubMed ID: 6593602
    [Abstract] [Full Text] [Related]

  • 15. Hypoxanthine and Mcardle disease: a clue to metabolic stress in the working forearm.
    Brooke MH, Patterson VH, Kaiser KK.
    Muscle Nerve; 1983 Nov 15; 6(3):204-6. PubMed ID: 6574314
    [Abstract] [Full Text] [Related]

  • 16. Gentamicin treatment in McArdle disease: failure to correct myophosphorylase deficiency.
    Schroers A, Kley RA, Stachon A, Horvath R, Lochmüller H, Zange J, Vorgerd M.
    Neurology; 2006 Jan 24; 66(2):285-6. PubMed ID: 16434679
    [No Abstract] [Full Text] [Related]

  • 17. [McArdle disease: report of four brothers with myophosphorylase deficiency].
    López Martín A, Baños Madrid RI, García-Estañ Candela J, García Pérez B, Pérez Bautista FJ, Salmerón P.
    An Med Interna; 2001 Mar 24; 18(3):136-8. PubMed ID: 11594178
    [Abstract] [Full Text] [Related]

  • 18. Phenotype consequences of myophosphorylase dysfunction: insights from the McArdle mouse model.
    Brull A, de Luna N, Blanco-Grau A, Lucia A, Martin MA, Arenas J, Martí R, Andreu AL, Pinós T.
    J Physiol; 2015 Jun 15; 593(12):2693-706. PubMed ID: 25873271
    [Abstract] [Full Text] [Related]

  • 19. MCARDLE'S DISEASE: HEREDITARY MYOPATHY DUE TO ABSENCE OF MUSCLE PHOSPHORYLASE.
    FAHN S, SCHOTLAND DL, ROWLAND LP.
    Trans Am Neurol Assoc; 1963 Jun 15; 88():145-7. PubMed ID: 14272202
    [No Abstract] [Full Text] [Related]

  • 20. 31-P NMR characterization of the metabolic anomalies associated with the lack of glycogen phosphorylase activity in human forearm muscle.
    Bendahan D, Confort-Gouny S, Kozak-Ribbens G, Cozzone PJ.
    Biochem Biophys Res Commun; 1992 May 29; 185(1):16-21. PubMed ID: 1599452
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.